The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults

被引:94
作者
Sulkowski, MS
Chaisson, RE
Karp, CL
Moore, RD
Margolick, JB
Quinn, TC
机构
[1] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA
[5] NIAID, Immunoregulat Lab, Bethesda, MD 20892 USA
关键词
D O I
10.1086/314491
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of acute coinfections on plasma human immunodeficiency virus (HIV) load and immune activation markers was evaluated. Thirty-two HIV-infected persons were prospectively enrolled; 18 had pre-illness, acute, and follow-up specimens. Plasma HIV RNA levels were determined by reverse transcriptase-polymerase chain reaction, and serum levels of activation markers, including tumor necrosis factor (TNF)-alpha, soluble (s) TNF receptors (R)-I and -II, interleukin (IL)-2, IL-6, IL-10, sIL-2R, sCD4, and sCD8, were assessed by commercial ELISAs. Median plasma HIV load increased 7.8-fold during illness (P =.001) and decreased 1.5-fold (P =.01) during convalescence (median, 15 days), Significant virus load reductions were limited to subjects with clinical recovery. By regression analysis, changes in plasma HIV RNA were significantly associated with changes in sTNFR-I, sTNFR-II, and sIL-2R. Increased HIV replication during acute coinfections is associated with in vivo immune activation, which underscores the need to prevent and promptly treat intercurrent illnesses.
引用
收藏
页码:1642 / 1648
页数:7
相关论文
共 37 条
  • [1] STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS
    ADERKA, D
    ENGELMANN, H
    MAOR, Y
    BRAKEBUSCH, C
    WALLACH, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) : 323 - 329
  • [2] CORRELATES OF THE RATE OF DECLINE OF CD4+ LYMPHOCYTES AMONG INJECTION-DRUG USERS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
    ALCABES, P
    SCHOENBAUM, EE
    KLEIN, RS
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (09) : 989 - 1000
  • [3] Inhibition of cytokine-driven human immunodeficiency virus type 1 replication by protease inhibitor
    AlHarthi, L
    Roebuck, KA
    Kessler, H
    Landay, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (05) : 1175 - 1179
  • [4] The tumor necrosis factor ligand and receptor families
    Bazzoni, F
    Beutler, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) : 1717 - 1725
  • [5] Soluble tumor necrosis factor-alpha receptor type II (sTNF alpha RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients
    Bilello, JA
    Stellrecht, K
    Drusano, GL
    Stein, DS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) : 464 - 467
  • [6] Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine
    Brichacek, B
    Swindells, S
    Janoff, EN
    Pirruccello, S
    Stevenson, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) : 1191 - 1199
  • [7] IDENTIFICATION OF 2 TYPES OF TUMOR-NECROSIS-FACTOR RECEPTORS ON HUMAN CELL-LINES BY MONOCLONAL-ANTIBODIES
    BROCKHAUS, M
    SCHOENFELD, HJ
    SCHLAEGER, EJ
    HUNZIKER, W
    LESSLAUER, W
    LOETSCHER, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) : 3127 - 3131
  • [8] A study of HIV RNA viral load in AIDS patients with bacterial pneumonia
    Bush, CE
    Donovan, RM
    Markowitz, NP
    Kvale, P
    Saravolatz, LD
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (01): : 23 - 26
  • [9] BUSH CE, 1997, 4 C RETR OPP INF
  • [10] Impact of opportunistic disease on survival in patients with HIV infection
    Chaisson, RE
    Gallant, JE
    Keruly, JC
    Moore, RD
    [J]. AIDS, 1998, 12 (01) : 29 - 33